Philips Appoints Robert Cascella to Lead its Cluster of Global Imaging Businesses

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) has announced the appointment of Mr. Robert Cascella to lead Philips' multi-billion euro cluster of Imaging businesses. These businesses capitalize on the rapidly transforming global healthcare industry, in particular in the areas of integrated diagnostic imaging and image-guided minimally invasive therapy solutions. He succeeds Gene Saragnese, who has decided to retire from Philips per May 1, 2015. Mr. Cascella will hold the title of Executive Vice President, Royal Philips.

Mr. Cascella joins Philips with over thirty years of experience in the healthcare industry. He spent the previous ten years at Hologic Inc., a global leader in women’s health, where he held the position of President and later CEO. During this period, Hologic broadly diversified its product portfolio and substantially grew revenues through a combination of innovative product development and acquisitions, as well as the establishment of exceptionally strong customer relationships.

Advanced diagnostic imaging and image-guided minimally invasive therapies, supported by integrated clinical informatics, are among the pillars of modern healthcare. In his new role, Mr. Cascella will be the CEO of the Business Group Diagnostic Imaging (MRI, CT, PET and X-Ray), while also overseeing the other two Business Groups in the cluster of Imaging businesses: Image-Guided Therapy, which includes the recently acquired Volcano business, and Ultrasound. Mr. Cascella will be based in Andover and Amsterdam and will report directly to Frans van Houten, CEO of Royal Philips.

"Rob has an impressive track record in value creation in the healthcare industry, with a strong focus on integrated solutions," said Frans van Houten. "He will bring a wealth of expertise in diagnostic imaging, together with deep customer insights at a crucial time for Philips, as we accelerate our transformation to become a global leader in HealthTech and shape the future of the industry."

Commenting on his appointment, Mr. Cascella said: "I am absolutely thrilled to be joining Philips. The company's tremendous history of innovation, its leading position in medical imaging and its customer-centric focus on the HealthTech opportunity will make it both an exciting and rewarding place to work. I look forward to contributing to its future success."

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 105,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...